Apimeds Pharmaceuticals US Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HEMENWAY TRUST CO LLC | 05/07/2026 | 274.00 K | $490.30 K | 0.00% | 1.77% |
| VANGUARD CAPITAL MANAGEMENT LLC | 05/15/2026 | 95.93 K | $171.62 K | 100.00% | 0.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 40.05 K | $71.67 K | 14.80% | 0.26% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 24.04 K | $43.01 K | 100.00% | 0.16% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 10.55 K | $18.88 K | 100.00% | 0.07% |
| UBS GROUP AG | 05/05/2026 | 4.19 K | $7.49 K | 619.42% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apimeds Pharmaceuticals US Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Apimeds Pharmaceuticals US Inc.. The most heavily invested institutionals were:
TWO SIGMA SECURITIES, LLC: 0
VANGUARD GROUP INC: 58,992
2.89% of Apimeds Pharmaceuticals US Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 58.99 K shares in the last 24 months. This purchase volume represents approximately $77.28 K in transactions.